Detalhe da pesquisa
1.
Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance.
Int J Mol Sci
; 23(3)2022 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35163067
2.
Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
Brain
; 143(11): 3273-3293, 2020 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141183
3.
A New Generation Somatostatin-Dopamine Analogue Exerts Potent Antitumoral Actions on Pituitary Neuroendocrine Tumor Cells.
Neuroendocrinology
; 110(1-2): 70-82, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31272096
4.
Statins Directly Regulate Pituitary Cell Function and Exert Antitumor Effects in Pituitary Tumors.
Neuroendocrinology
; 110(11-12): 1028-1041, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31940630
5.
Metformin and simvastatin exert additive antitumour effects in glioblastoma via senescence-state: clinical and translational evidence.
EBioMedicine
; 90: 104484, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36907105
6.
SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances.
J Exp Clin Cancer Res
; 41(1): 39, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086552
7.
A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors.
Clin Cancer Res
; 26(4): 957-969, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31624102
8.
Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms.
J Clin Endocrinol Metab
; 104(8): 3501-3513, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30860580
9.
Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.
Sci Rep
; 8(1): 6173, 2018 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29670116